Augmedix, a medical documentation company, is expected to conduct a public offering of its stock. The deal is contingent upon the approval of its application for listing on the Nasdaq.
The stock is currently traded on the Over-the-Counter Market under the ticker symbol "AUGX," and if approved, it will trade on the Nasdaq under the same symbol.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.77 - $2.35 |
|---|---|
| 50-day moving average | $2.30 |
| 200-day moving average | $2.87 |
| Wall St. target price | $2.92 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.47 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
| Revenue TTM | $51.6 million |
|---|---|
| Gross profit TTM | $14 million |
| Return on assets TTM | -30.61% |
| Return on equity TTM | -329.78% |
| Profit margin | -46.23% |
| Book value | $0.21 |
| Market Capitalization | $116.2 million |
TTM: trailing 12 months
We're not expecting Augmedix to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Augmedix's shares have ranged in value from as little as $0.7711 up to $2.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Augmedix's is -0.19. This would suggest that Augmedix's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Augmedix has bucked the trend.
To put Augmedix's beta into context you can compare it against those of similar companies.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020.
Investing is more accessible than you may think. Here are five ways to start investing when you have little money to invest.
These are the stocks to buy when you don’t have much to spend.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
We review the Kalshi trading platform and explain how investors can use it as a hedge for their investments.
Market capitalization can help investors determine a company’s market value to predict growth, but there are some considerations to keep in mind.
Compare pros, cons, research tools and reviews for these two trading platforms.
Fractional shares are fractions of company shares. Sometimes they’re made by brokers to allow those with limited funds to get access to stocks.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
A deep dive into the highlights and limitations of Robinhood.